Article
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome.
British journal of cancer - 1 Jun 2018
Thomsen Maria, Skovlund Eva, Sorbye Halfdan, Bolstad Nils, Nustad Kjell Johannes, Glimelius Bengt, Pfeiffer Per, Kure Elin H, Johansen Julia S, Tveit Kjell Magne, Christoffersen Thoralf, Guren Tormod Kyrre
Abstract excerpt
BACKGROUND: Mutation status of RAS and BRAF, as well as serum levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9), are biomarkers used in clinical management of patients with gastrointestinal cancers. This study aimed to examine the prognostic role of these biomarkers in a patient population that started first-line chemotherapy for unresectable metastatic colorectal cancer (mCRC) in...
Topics
Join the communities discussing this publication.